BioStorage® Technologies Accelerates Global Sample Management Service Expansion in the U.S. and China
INDIANAPOLIS, Oct. 27, 2016 /PRNewswire/ -- BioStorage Technologies, Inc. the global leader in comprehensive sample lifecycle management for the life sciences industry and subsidiary of Brooks Life Science Systems, today announced expansion of its sample storage services in the U.S. and bioprocessing capabilities in China. The company recently entered into an agreement with Shanghai Outdo Biotechnology Co., Ltd and RUCDR Infinite Biologics at Rutgers University to provide advanced sample bioprocessing, at the Outdo Biobank in Shanghai.
The Outdo Biobank represents the largest and most thoroughly characterized tissue bank in China with more than 200,000 samples, and an inventory growing on a daily basis. Through the partnership, the Outdo Biobank will provide a full spectrum of advanced lab services for researchers, academic institutions, pharma R&D and CRO companies worldwide.
"It has been an exciting time for BioStorage as we continue our strategic growth in China, and through our collaboration with SOBC, we now have the ability to extend our global solutions, standards and technology platforms to samples undergoing bioprocessing at SOBC," said Martin Long, Vice President of BioStorage Technologies. "SOBC is the gold standard for biobanks in China and share our dedication for optimal quality and service, as such we anticipate the alliance will bring long-term success and continued growth for all sides."
BioStorage Technologies also announced plans to expand its state-of-the-art biorepository facility in Indianapolis. The expansion represents a 30 percent increase in footprint and a 55 percent increase in new freezers. Additionally, this Center of Excellence facility will have expanded bioprocessing capabilities featuring the latest innovations in sample management automation and cryogenic storage solutions.
"The investment in the expansion of our BioStorage Technologies facility in North America and our capabilities in China underscores our commitment to provide our customers with global services that extend the utility of their samples and ultimately empower their research through smarter sample asset management," said Dusty Tenney, President of Brooks Life Science Systems.
Serving hundreds of bioscience clients around the world including the top 20 major pharmaceutical and biotechnology companies, BioStorage Technologies' expansion in the U.S. and China supports the growth of the global life sciences market while also enabling advancements in targeted medicine through advanced bioprocessing and biobanking solutions.
For more information, visit www.brooks.com/lifescience
About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc., a subsidiary of Brooks Life Science Systems, is the premier, global leader of comprehensive sample lifecycle management solutions for the life science industry. Our solutions include flexible onsite or offsite sample storage models, an expert team of sample management consultants, industry-leading temperature-controlled storage facilities, global cold-chain logistics services including the Relofleet® mobile biorepository, innovative sample bioprocessing and ISIDOR®, our transformational informatics platform for integrating research samples and sample intelligence data. The company supports hundreds of lifescience clients around the world including the top 20 biopharmaceutical companies in maximizing opportunities, minimizing risk and reducing costs.
For more information, visit www.biostorage.com or call +1 866 697 2675 for North America, +49 6155 898 1011 for Europe, +65 31576199 for Singapore or +86 10 8587 2390 for China.
About Shanghai Biotech Co., Ltd (SOBC):
Founded in 2003 by National Engineering Center for Biochip at Shanghai, the Shanghai Outdo Biotech Co., Ltd (SOBC) has evolved into an integrated Biotech involving the Biobank, Laboratory Developed Test (LDT) manufacturers, Clinic molecular testing lab and a top CRO thereby expanding its advanced genomic and molecular pathology services. As the very first China-based commercial biorepository, and the general executive unit of Biobank Branch, China Medicinal Technology Association (BBCMBA) and China Biobank Alliance (CBA), the lead unit of National Technical Committee of Biospecimen Standardization and Administration (NTCBSA), the Shanghai Outdo Biobank, together with the newly launched Shanghai Zhangjiang Biobank, is developing as a leading center with intellectual expertise and advanced biobanking facilities, offering a full spectrum of sample management services.
Press Contact:
Michael Clark
Miller Brooks, Inc.
+1-317-873-8100
michael@millerbrooks.com
Share this article